Iridium (NASDAQ: IRDM) preps Rocket Lab takeover pitch to investors

Rhea-AI Filing Summary

Iridium Communications Inc. (IRDM) distributed internal talking points about a proposed acquisition of Iridium by Rocket Lab Corporation. The communication explains that Rocket Lab has filed a Registration Statement on Form S-4, which includes Iridium’s proxy statement and Rocket Lab’s prospectus, and that this registration statement is not yet effective.

Iridium stockholders will later receive the finalized proxy statement/prospectus seeking approval of transaction-related proposals. The text emphasizes that neither this communication nor the preliminary proxy statement/prospectus constitutes an offer to sell or a solicitation to buy securities, and that Rocket Lab cannot sell the referenced common stock until the Form S-4 becomes effective.

The communication urges investors to read the Form S-4, proxy statement/prospectus and related SEC filings when available, and identifies Iridium directors and its chief financial officer, as well as Rocket Lab, as potential participants in the solicitation. It also includes extensive forward-looking statement cautions, listing numerous risks that could cause actual results or the completion and benefits of the proposed transaction to differ materially from expectations.

Key Terms

Registration Statement on Form S-4, proxy statement/prospectus, participants in Iridium’s solicitation, forward-looking statements, +2 more

6 terms

Registration Statement on Form S-4 regulatory

"Rocket Lab h (the “SEC”) a Registration Statement on Form S-4"

A registration statement on Form S-4 is a formal filing with the U.S. Securities and Exchange Commission used when a company issues shares or other securities as part of a merger, acquisition, exchange offer or similar corporate deal. It bundles the transaction terms, financial statements, risk factors and shareholder vote materials so investors can assess the deal; think of it as a detailed prospectus or buyer’s packet that explains what you would own and how the deal could change your stake.

proxy statement/prospectus regulatory

"includes the proxy statement of Iridium that will also constitute a prospectus"

A proxy statement or prospectus is a document that companies send to shareholders to provide important information about upcoming decisions or investments, such as voting on company issues or offering new shares to the public. It helps investors understand the details and risks involved, enabling them to make informed choices about their ownership or involvement with the company.

participants in Iridium’s solicitation regulatory

"may be considered participants in Iridium’s solicitation"

forward-looking statements regulatory

"This communication contains “forward-looking statements” within the meaning"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

merger agreement regulatory

"could give rise to the termination of the merger agreement"

A merger agreement is a binding contract that lays out the exact terms for two companies to combine, including the price, what each side will deliver, and the conditions that must be met before the deal is completed. Investors care because it sets the timetable, payouts and risks — like a blueprint or prenup that shows whether the deal is likely to close, how ownership will change, and what could cancel or alter the payout they expect.

periodic reports regulatory

"the periodic reports that Rocket Lab and Iridium file with the SEC"

Regularly scheduled documents that a publicly traded company must provide to disclose its financial results, business operations, risks and significant events — like a report card showing revenue, profits, cash flow and key changes over a set period. Investors use these reports to judge a company's health and trends, compare performance over time, and make informed buy, hold or sell decisions; they act as a routine check-up for financial transparency.

FAQ

What transaction involving IRDM is described in this Form 425 communication?

The communication describes a proposed acquisition of Iridium Communications Inc. (IRDM) by Rocket Lab Corporation. It explains that the transaction will be submitted to Iridium stockholders for approval through a proxy statement/prospectus included in Rocket Lab’s Registration Statement on Form S-4.

What is the purpose of Rocket Lab’s Form S-4 related to IRDM?

Rocket Lab has filed a Registration Statement on Form S-4 that includes Iridium’s proxy statement and Rocket Lab’s prospectus. Once effective and finalized, it will be sent to Iridium stockholders to seek approval of transaction-related proposals for the proposed acquisition.

Can Rocket Lab currently sell the common stock referenced for the IRDM deal?

No. The communication states that Rocket Lab may not sell the common stock referenced in the proxy statement/prospectus until the Form S-4 becomes effective. The preliminary proxy statement/prospectus and this communication are not offers to sell or solicitations to buy securities.

Where can IRDM investors obtain the Form S-4 and proxy statement/prospectus?

Investors can obtain the Form S-4 and related proxy statement/prospectus free of charge from the SEC’s website (www.sec.gov). Copies filed by Rocket Lab or Iridium may also be obtained free from their respective investor relations websites or email contacts listed in the communication.

Who are the participants in Iridium’s solicitation related to the Rocket Lab transaction?

The communication lists Iridium’s board members and its chief financial officer, Vincent J. O’Neill, as potential participants in Iridium’s solicitation. It also notes that Rocket Lab may be deemed a participant, with details provided in Amendment No. 1 to the Form S-4 filed on August 24, 2026.

What key risks are highlighted for the proposed Rocket Lab–IRDM transaction?

The text highlights risks such as failure to complete the transaction, inability to obtain stockholder or regulatory approvals, potential termination of the merger agreement, integration challenges, possible litigation, business disruptions, financing risks, and broader economic, regulatory, and market uncertainties.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 05:24 PM Accepted by SEC EDGAR 08/26/2026 - 05:21 PM Learn about SEC filing dates

Filed by Iridium Communications Inc.

Pursuant to Rule 425 Under the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934

Subject Company: Iridium Communications Inc.

Commission File No.: 001-33963

The following talking points were distributed to employees of Iridium Communications Inc. (“Iridium”) on August 26, 2026 in connection with the proposed acquisition of Iridium by Rocket Lab Corporation:

 

Talking Points – Iridium – Rocket Lab

ROCKET LAB:

Talking Points for All Audiences

· We’re excited to join forces with Rocket Lab to create a vertically integrated space company that designs, builds, launches, and operates satellite networks.

· This transaction reinforces our commitment to supporting national security, resilient communications, and America’s continued leadership in space.

· Both Iridium and Rocket Lab are long-time trusted partners of the United States Government.

o Iridium brings 25 years of experience supporting the U.S. Department of Defense and federal agencies, including the Space Development Agency’s PWSA Ground Management and Integration (GMI) program.

o Rocket Lab serves the defense and intelligence community through Rocket Lab National Security (RLNS), its wholly owned U.S. subsidiary. They recently demonstrated their rapid-response capabilities for the U.S. Space Force, completing the Victus Haze mission from launch through spacecraft deployment in just 16 hours and 42 minutes.

· Together, we will be better positioned to accelerate innovation across mission-critical satellite services, including communications, resilient PNT, aviation safety, and emerging space-based applications.

o We are bringing together unique sets of expertise and experience from two separate ends of the industry. The knowledge sharing and working together on the art of the possible makes this an exciting time for both companies.

o We aren’t ready to share what those things are yet, but they fit neatly into the strategy behind this deal.

· By combining Rocket Lab’s launch and satellite manufacturing capabilities with Iridium’s global network, spectrum assets, operational expertise, and partner ecosystem, we will be able to deliver greater value to customers and stakeholders.

o Customers should benefit from faster innovation, accelerated investment in next-generation services, and a more integrated portfolio of space solutions.

o By bringing together Rocket Lab's expertise in building and launching spacecraft with Iridium's proven global communications network, we'll be able to develop new capabilities more quickly while continuing to provide the resilient, mission-critical services our customers rely on.

· Until the transaction closes, it is business as usual. Rocket Lab and Iridium will continue to operate as separate companies, with no changes to our operations, customers, products, or services. For additional details I refer you to our public materials.

For additional assistance contact Executive Director of Communication for Iridium, Jordan Hassin (Jordan.Hassin@iridium.com)

Additional Information and Where to Find It

This communication is being made in respect of a proposed transaction involving Rocket Lab Corporation (“Rocket Lab”) and Iridium Communications Inc. (“Iridium”). In connection with the proposed transaction, Rocket Lab has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-4 that includes the proxy statement of Iridium that will also constitute a prospectus of Rocket Lab, but which is not yet effective. When the proxy statement/prospectus is finalized, it will be sent to the stockholders of Iridium seeking their approval of certain transaction-related proposals. This communication is not a substitute for the proxy statement/prospectus or any other documents which Rocket Lab or Iridium may file with the SEC in connection with the proposed transaction.

Rocket Lab may not sell the common stock referenced in the proxy statement/prospectus until the Registration Statement on Form S-4 filed with the SEC becomes effective. The preliminary proxy statement/prospectus and this communication are not offers to sell any securities, are not soliciting an offer to buy any securities in any state where the offer and sale is not permitted and are not a solicitation of any vote or approval.

ROCKET LAB AND IRIDIUM URGE INVESTORS AND SECURITY HOLDERS TO READ THE REGISTRATION STATEMENT ON FORM S-4, THE RELATED PROXY STATEMENT/PROSPECTUS INCLUDED THEREIN AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. 

Investors and security holders will be able to obtain these materials (when they are available and filed) free of charge at the SEC’s website, www.sec.gov. Copies of documents filed with the SEC by Rocket Lab (when they become available) may be obtained free of charge on Rocket Lab’s website at https://investors.rocketlabcorp.com/financial-information/sec-filings or by contacting Rocket Lab’s Investor Relations Department at investors@rocketlabusa.com. Copies of documents filed with the SEC by Iridium (when they become available) may be obtained free of charge on Iridium’s website at https://investor.iridium.com/sec-filings by contacting Iridium’s Investor Relations Department at investor.relations@iridium.com.

Participants in the Solicitation

Robert H. Niehaus, Louis M. Alterman, Thomas C. Canfield, Matthew J. Desch, Thomas J. Fitzpatrick, L. Anthony Frazier, Suzanne E. McBride, Eric T. Olson, Kay N. Sears, Monique S. Shivanandan and Jacqueline E. Yeaney, all of whom are members of Iridium’s board of directors, and Vincent J. O’Neill, Iridium’s chief financial officer, may be considered participants in Iridium’s solicitation. Information regarding such participants, including their direct or indirect interests, by security holdings or otherwise, is included in the Amendment No. 1 to Form S-4 Registration Statement filed with the SEC on August 24, 2026. Rocket Lab may also be deemed to be a participant in Iridium’s solicitation; information regarding Rocket Lab is included in the Amendment No. 1 to Form S-4 Registration Statement filed with the SEC on August 24, 2026. Copies of these documents may be obtained, free of charge, from the SEC or Iridium as described in the preceding paragraph.

Cautionary Note Regarding Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the federal securities laws. These forward-looking statements are based on Rocket Lab’s and Iridium’s current expectations, estimates and projections about the proposed transaction and the potential benefits thereof, its business and industry, management’s beliefs and certain assumptions made by Rocket Lab and Iridium, all of which are subject to change. In this context, forward-looking statements often address expected future events, including future business and financial performance and financial condition. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof, expectations regarding regulatory approvals, and intentions with respect to financing the transaction. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or implied in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the completion of the proposed transaction on anticipated terms and timing, or at all, including obtaining stockholder and regulatory approvals and satisfying other conditions to the completion of the transaction; (ii) the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement, including the receipt by Iridium of an unsolicited proposal from a third party; (iii) failure to realize the anticipated benefits of the proposed transaction on a timely basis or at all, including anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, the integration of the businesses of Rocket Lab and Iridium, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of Rocket Lab’s and Iridium’s businesses; (iv) Rocket Lab’s and Iridium’s ability to implement their business strategies; (v) potential litigation relating to the proposed transaction that could be instituted against Rocket Lab, Iridium or their respective directors, managers, or officers, including the effects of any outcomes related thereto; (vi) the risk that disruptions from the proposed transaction will harm Rocket Lab’s or Iridium’s businesses, including current plans and operations, or will otherwise divert management time from ongoing business operations on transaction-related issues; (vii) the ability of Rocket Lab or Iridium to retain and hire key personnel; (viii) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction; (ix) fluctuations in, and uncertainty as to the long-term value of, Rocket Lab or Iridium common stock (including as relating to the risk that any announcements related to the proposed transaction could have adverse effects on the market price of such stock); (x) legislative, regulatory and economic developments affecting Rocket Lab’s and Iridium’s businesses, including actions by government agencies and third parties; (xi) general economic and market developments and conditions, potential changes to international trade relations, geopolitical conflicts and effects from global pandemics, epidemics, or other public health crises; (xii) the evolving legal, regulatory and tax regimes under which Rocket Lab and Iridium operate; (xiii) restrictions during the pendency of the proposed transaction that may impact Rocket Lab’s or Iridium’s ability to pursue certain business opportunities or strategic transactions; (xiv) unexpected costs, charges or expenses resulting from the proposed transaction; (xv) risks that any debt or other financing anticipated in connection with the proposed transaction is not obtained or that such financing cannot be obtained on the anticipated timing or terms or unexpected costs or expenses in connection therewith; and (xvi) the other risks and uncertainties, as described in the periodic reports that Rocket Lab and Iridium file with the SEC. These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the proxy statement/prospectus to be filed with the SEC in connection with the proposed transaction. Neither Rocket Lab nor Iridium assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Forward-looking statements included in this communication are made as of the date of this communication.